Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion
Lauder, S. N.
AffiliationDivision of Infection and Immunity, Cardiff University School of Medicine, SIURI, Cardiff, CF14 4XN, UK.
MetadataShow full item record
AbstractAlthough metastatic disease is responsible for the majority of cancer deaths, tests of novel immunotherapies in mouse tumour models often focus on primary tumours without determining whether these therapies also target metastatic disease. This study examined the impact of depleting Foxp3(+) regulatory T cells (Treg), on lung metastases, using a mouse model of breast cancer. After Treg-depletion, generation of an immune response to the primary tumour was a critical determinant for limiting development of metastasis. Indeed, resection of the primary tumour abrogated any effect of Treg-depletion on metastases. In addition, whilst the immune response, generated by the primary tumour, prevented metastases development, it had little impact on controlling established disease. Collectively, the data indicate that metastatic cells in the lung are not controlled by immune responses induced by the primary tumour. These findings indicate that targeting Tregs alone will not suffice for treating lung metastases.
CitationE. Hughes, S. N. Lauder, K. Smart et al. Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion. Cancer Immunol Immunother. 2020.
JournalCancer Immunology Immunotherapy
- Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.
- Authors: Chaudhary B, Abd Al Samid M, al-Ramadi BK, Elkord E
- Issue date: 2014 Jul
- Oral tolerance to cancer can be abrogated by T regulatory cell inhibition.
- Authors: Whelan MC, Casey G, Larkin JO, Guinn BA, O'Sullivan GC, Tangney M
- Issue date: 2014
- Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy.
- Authors: Coe D, Begom S, Addey C, White M, Dyson J, Chai JG
- Issue date: 2010 Sep
- Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC.
- Authors: Kaewkangsadan V, Verma C, Eremin JM, Cowley G, Ilyas M, Eremin O
- Issue date: 2018 Feb 2
- [Prognostic value of tumor infiltration immune cells in pancreatic cancer].
- Authors: Zhao KL, Liu J, Jiang WN, Hao JH
- Issue date: 2018 Jun 1